These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 8335931)

  • 1. A conserved binding site on the receptor for polymeric Ig is homologous to CDR1 of Ig V kappa domains.
    Bakos MA; Kurosky A; Czerwinski EW; Goldblum RM
    J Immunol; 1993 Aug; 151(3):1346-52. PubMed ID: 8335931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of a critical binding site for human polymeric Ig on secretory component.
    Bakos MA; Kurosky A; Goldblum RM
    J Immunol; 1991 Nov; 147(10):3419-26. PubMed ID: 1940346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Probing the topography of free and polymeric Ig-bound human secretory component with monoclonal antibodies.
    Bakos MA; Kurosky A; Woodard CS; Denney RM; Goldblum RM
    J Immunol; 1991 Jan; 146(1):162-8. PubMed ID: 1701790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rat secretory component binds poorly to rodent IgM.
    Underdown BJ; Switzer I; Jackson GD
    J Immunol; 1992 Jul; 149(2):487-91. PubMed ID: 1624795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fine specificity of ligand-binding domain 1 in the polymeric Ig receptor: importance of the CDR2-containing region for IgM interaction.
    Røe M; Norderhaug IN; Brandtzaeg P; Johansen FE
    J Immunol; 1999 May; 162(10):6046-52. PubMed ID: 10229845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TcR recognition of the MHC-peptide dimer: structural properties of a ternary complex.
    Vasmatzis G; Cornette J; Sezerman U; DeLisi C
    J Mol Biol; 1996 Aug; 261(1):72-89. PubMed ID: 8760503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The three complementarity-determining region-like loops in the second extracellular domain of human Fc alpha/mu receptor contribute to its binding of IgA and IgM.
    Yang X; Zhao Q; Zhu L; Zhang W
    Immunobiology; 2013 May; 218(5):798-809. PubMed ID: 23182711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contributions of amino acid side chains to the kinetics and thermodynamics of the bivalent binding of protein L to Ig kappa light chain.
    Svensson HG; Wedemeyer WJ; Ekstrom JL; Callender DR; Kortemme T; Kim DE; Sjöbring U; Baker D
    Biochemistry; 2004 Mar; 43(9):2445-57. PubMed ID: 14992582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of a monoclonal antibody, D73H, that maps to a highly conserved region on fibrinogen Bbeta chain.
    Rybarczyk BJ; Pereira M; Simpson-Haidaris PJ
    Thromb Haemost; 2000 Jul; 84(1):43-8. PubMed ID: 10928468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Display of somatostatin-related peptides in the complementarity determining regions of an antibody light chain.
    Simon PJ; Brogle KC; Wang B; Kyle DJ; Soltis DA
    Arch Biochem Biophys; 2005 Aug; 440(2):148-57. PubMed ID: 16051181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NMR analysis of the interaction between protein L and Ig light chains.
    Enokizono J; Wikström M; Sjöbring U; Björck L; Forsén S; Arata Y; Kato K; Shimada I
    J Mol Biol; 1997 Jul; 270(1):8-13. PubMed ID: 9231896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal structure of HEL4, a soluble, refoldable human V(H) single domain with a germ-line scaffold.
    Jespers L; Schon O; James LC; Veprintsev D; Winter G
    J Mol Biol; 2004 Apr; 337(4):893-903. PubMed ID: 15033359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Building novel binding ligands to B7.1 and B7.2 based on human antibody single variable light chain domains.
    van den Beucken T; van Neer N; Sablon E; Desmet J; Celis L; Hoogenboom HR; Hufton SE
    J Mol Biol; 2001 Jul; 310(3):591-601. PubMed ID: 11439026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secretory component delays the conversion of secretory IgA into antigen-binding competent F(ab')2: a possible implication for mucosal defense.
    Crottet P; Corthésy B
    J Immunol; 1998 Nov; 161(10):5445-53. PubMed ID: 9820520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutational analysis of polymeric immunoglobulin receptor/ligand interactions. Evidence for the involvement of multiple complementarity determining region (CDR)-like loops in receptor domain I.
    Coyne RS; Siebrecht M; Peitsch MC; Casanova JE
    J Biol Chem; 1994 Dec; 269(50):31620-5. PubMed ID: 7989333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo experiments involving secretory component in the rat hepatic transfer of polymeric IgA from blood into bile.
    Lemaître-Coelho I; Altamirano GA; Barranco-Acosta C; Meykens R; Vaerman JP
    Immunology; 1981 Jun; 43(2):261-70. PubMed ID: 7251055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro comparison of the biologic activities of monoclonal monomeric IgA, polymeric IgA, and secretory IgA.
    Renegar KB; Jackson GD; Mestecky J
    J Immunol; 1998 Feb; 160(3):1219-23. PubMed ID: 9570537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural insight into the specific interaction between murine SHPS-1/SIRP alpha and its ligand CD47.
    Nakaishi A; Hirose M; Yoshimura M; Oneyama C; Saito K; Kuki N; Matsuda M; Honma N; Ohnishi H; Matozaki T; Okada M; Nakagawa A
    J Mol Biol; 2008 Jan; 375(3):650-60. PubMed ID: 18045614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and purification of biologically active domain I of the human polymeric immunoglobulin receptor.
    Bakos MA; Widen SG; Goldblum RM
    Mol Immunol; 1994 Feb; 31(2):165-8. PubMed ID: 8309479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conservation of a polyanion binding site in mammalian and avian CD4.
    Parish CR; Warren HS
    Immunology; 1991 Oct; 74(2):191-6. PubMed ID: 1748468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.